摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Benzyloxy-2-isothiocyanato-benzene | 914638-41-8

中文名称
——
中文别名
——
英文名称
1-Benzyloxy-2-isothiocyanato-benzene
英文别名
1-(Benzyloxy)-2-isothiocyanatobenzene;1-isothiocyanato-2-phenylmethoxybenzene
1-Benzyloxy-2-isothiocyanato-benzene化学式
CAS
914638-41-8
化学式
C14H11NOS
mdl
——
分子量
241.313
InChiKey
CUBKADTWNGWBCR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    53.7
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    1-Benzyloxy-2-isothiocyanato-benzene3-amino-6-chloro-2-hydroxy-N,N-dimethylbenzenesulfonamideN,N-二甲基甲酰胺 为溶剂, 生成 3-[3-(2-Benzyloxy-phenyl)-thioureido]-6-chloro-2-hydroxy-N,N-dimethyl-benzenesulfonamide
    参考文献:
    名称:
    N,N′-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors
    摘要:
    A series of N-(2-hydroxy-3-sulfonamidobenzene)-N'-arylcyanoguanidines was prepared. In general, these compounds proved to be potent antagonists of CXCR2 while the selectivity versus CXCR1 ranged from non-selective to > 200-fold. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.08.042
点击查看最新优质反应信息

文献信息

  • [EN] DERIVATIVES OF PHENYL (THIO) UREA DEOXYTHYMIDINE AND USE THEREOF AS ANTIMALARIALS<br/>[FR] DÉRIVÉS DE PHÉNYL(THIO)URÉEDÉSOXYTHYMIDINE ET LEUR UTILISATION COMME ANTIPALUDIQUES
    申请人:UNIV DUNDEE
    公开号:WO2013014445A1
    公开(公告)日:2013-01-31
    Deoxythymidine derivatives according to formula (I) are disclosed. wherein: X may be O or S; and R1, R2, R3, R4 and R5 may each be independently selected from H, halo, C1-C6 alkyl, C1-C6 haloalkyl, nitro, phenyl, heteroaryl, substituted heteroaryl wherein the substituents may be C1-C6 alkyl or C1-C6 haloalkyl, benzyl, -CH2OAr, -OR6 and six-membered ring heterocyclic groups containing 1 or more O and/or N heteroatoms wherein any N heteroatom may be C1-C6 alkyl-substituted; and R6 may be selected from C1-C6 alkyl, phenyl, six-membered ring heterocyclic groups containing at least one O heteroatom, benzyl and substituted benzyl wherein the substituents may be halo, C1-C6 alkyl or C1-C6 alkoxy; R7 may be H or C1-C6 alkyl; and the stereochemistry of the bond depicted as 〰 is either α or β. Such derivatives have shown good inhibitory activity against malaria-causing parasites, e.g. Plasmodium falciparum, but have shown low levels of toxicity to human cells.
    根据公式(I),披露了脱氧胸苷衍生物。其中:X可以是O或S;R1、R2、R3、R4和R5可以分别独立地选择自H、卤素、C1-C6烷基、C1-C6卤代烷基、硝基、苯基、杂环芳基、取代的杂环芳基,其中取代基可以是C1-C6烷基或C1-C6卤代烷基、苄基、-CH2OAr、-OR6和含有1个或多个O和/或N杂原子的六元环杂环基团,其中任何N杂原子可以是C1-C6烷基取代的;R6可以选择自C1-C6烷基、苯基、含有至少一个O杂原子的六元环杂环基团、苄基和取代的苄基,其中取代基可以是卤素、C1-C6烷基或C1-C6烷氧基;R7可以是H或C1-C6烷基;而所示键的立体化学为α或β。这些衍生物已显示出对引起疟疾的寄生虫,如疟原虫(Plasmodium falciparum),具有良好的抑制活性,但对人类细胞的毒性水平较低。
  • [EN] GUANIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF<br/>[FR] DERIVES DE LA GUANIDINE ET UTILISATIONS THERAPEUTIQUES DE CEUX-CI
    申请人:MERCK PATENT GMBH
    公开号:WO2006010422A1
    公开(公告)日:2006-02-02
    Compounds of the formula (I) in which the radicals R and R1 to R10 are as defined in the description, processes for the preparation of them, use thereof for the treatment of cardiovascular diseases, and pharmaceutical compositions comprising them.
    式(I)中的化合物,其中基团R和R1至R10的定义如描述中所定义,它们的制备方法,用于治疗心血管疾病的用途,以及包含它们的药物组合物。
  • Guanidine Derivatives and Therapeutic Uses Thereof
    申请人:Roche Didier
    公开号:US20080004315A1
    公开(公告)日:2008-01-03
    Compounds of the formula (I): in which the radicals R and R 1 to R 10 are as defined in the description, processes for the preparation of them, use thereof for the treatment of cardiovascular diseases, and pharmaceutical compositions comprising them.
    式(I)的化合物:其中基团R和R1至R10如描述中所定义,它们的制备过程,它们用于治疗心血管疾病的用途,以及包含它们的药物组合物。
  • GUANIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF
    申请人:Merck Patent GmbH
    公开号:EP1771428A1
    公开(公告)日:2007-04-11
  • US7582656B2
    申请人:——
    公开号:US7582656B2
    公开(公告)日:2009-09-01
查看更多